Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 1.00 |
| ▸ | ABCC4 | O15439 | 1/20 | 1.00 |
| ▸ | GAA | P10253 | 1/20 | 1.00 |
| ▸ | TSHR | P16473 | 1/20 | 1.00 |
| ▸ | PTGS1 | P23219 | 1/20 | 1.00 |
| ▸ | HTT | P42858 | 1/20 | 1.00 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.73 |
| ▸ | FFAR1 | O14842 | 3/20 | 0.70 |
| ▸ | NR1H4 | Q96RI1 | 2/20 | 0.66 |
| ▸ | RORC | P51449 | 1/20 | 0.62 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.60 |
| ▸ | CA2 | P00918 | 1/20 | 0.60 |
| ▸ | CAMK2A | Q9UQM7 | 1/20 | 0.60 |
| ▸ | MEN1 | O00255 | 1/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.58 |
| ▸ | RXRA | P19793 | 3/20 | 0.56 |
| ▸ | RXRB | P28702 | 3/20 | 0.56 |
| ▸ | RXRG | P48443 | 3/20 | 0.56 |
| ▸ | MMP12 | P39900 | 1/20 | 0.55 |
| ▸ | HPGD | P15428 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Felbinac SCHEMBL2770717 | 0.98 | LMNA (0.95) | LMNAABCC4GAATSHRPTGS1 | |
| Felbinac SCHEMBL28286222 | 0.98 | LMNA (0.95) | LMNAABCC4GAATSHRPTGS1 | |
| Felbinac SCHEMBL28284752 | 0.98 | LMNA (0.95) | LMNAABCC4GAATSHRPTGS1 | |
| Felbinac SCHEMBL28284674 | 0.98 | LMNA (0.95) | LMNAABCC4GAATSHRPTGS1 | |
| Felbinac SCHEMBL8844919 | 0.98 | LMNA (0.95) | LMNAABCC4GAATSHRPTGS1 | |
| Felbinac SCHEMBL28284677 | 0.98 | LMNA (0.95) | LMNAABCC4GAATSHRPTGS1 | |
| Felbinac SCHEMBL28284672 | 0.98 | LMNA (0.95) | LMNAABCC4GAATSHRPTGS1 | |
| Felbinac SCHEMBL28286223 | 0.98 | LMNA (0.95) | LMNAABCC4GAATSHRPTGS1 | |
| Felbinac SCHEMBL384892 | 0.98 | LMNA (0.95) | LMNAABCC4GAATSHRPTGS1 | |
| Felbinac SCHEMBL28987839 | 0.96 | LMNA (0.91) | LMNAABCC4GAATSHRPTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 13645 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122031446-A | External pharmaceutical composition containing loxoprofen and felbinac | 第一三共健康事业株式会社 | 2026-05-15 | — | — | CN | claimed |
| CN-122031445-A | External pharmaceutical composition containing loxoprofen | 第一三共健康事业株式会社 | 2026-05-15 | — | — | CN | claimed |
| US-20260000741-A1 | METHOD OF AMELIORATING A PRO-INFLAMMATORY IMMUNOPHENOTYPE IN FARBER DISEASE SUBJECTS BY REPEATED ADMINISTRATION OF A RECOMBINANT HUMAN ACID CERAMIDASE | ACERAGEN INC (US) | 2026-01-01 | — | — | US | claimed |
| EP-4665315-A1 | METHODS OF PREPARATION OF ZINGERONE, COMPOSITIONS COMPRISING ZINGERONE, AND USES THEREFOR | Evithe Limited (NZ) | 2025-12-24 | — | — | EP | claimed |
| EP-4661890-A1 | PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS | Purdue Research Foundation (US) | 2025-12-17 | — | — | EP | claimed |
| EP-4654947-A1 | COMBINATION TREATMENT FOR NETHERTON SYNDROME | Quoin Pharmaceuticals, Inc. (US) | 2025-12-03 | — | — | EP | claimed |
| EP-3699174-B1 | COMPOSITION FOR PREVENTING OR TREATING TNF-RELATED DISEASES, CONTAINING DERIVATIVE AS ACTIVE INGREDIENT, AND METHOD FOR INHIBITING TNF ACTIVITY BY USING SAME | ILAB (KR) | 2025-11-12 | — | — | EP | claimed |
| EP-4330603-B1 | HEAT PUMP AND PHASE-CHANGE ENERGY STORAGE DEVICE | Arkeon Energy (FR) | 2025-11-12 | — | — | EP | claimed |
| US-20250332120-A1 | COMPOSITION FOR EXTERNAL PREPARATION | KAO CORPORATION (JP) | 2025-10-30 | — | — | US | claimed |
| EP-4628080-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF DRUG-RELATED PEPTIC ULCER COMPRISING ZASTAPRAZAN OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | Jeil Pharmaceutical Co., Ltd. (KR) | 2025-10-08 | — | — | EP | claimed |
| EP-0212617-B1 | PROCESS FOR PRODUCING 4-BIPHENYLYLACETIC ACID | LEDERLE (JAPAN) LTD. (JP) | 1989-01-11 | — | — | EP | claimed |
| EP-0214501-A2 | Emulsion compositions for administration of sparingly water soluble ionizable basic hydrophobic drugs | AMERICAN CYANAMID COMPANY (US) | 1987-03-18 | — | — | EP | claimed |
| EP-0212617-A1 | Process for producing 4-biphenylylacetic acid | LEDERLE (JAPAN) LTD. (JP) | 1987-03-04 | — | — | EP | claimed |
| EP-0127840-B1 | ANTIINFLAMMATORY ANALGESIC GELLED OINTMENTS | LEDERLE (JAPAN) LTD. (JP) | 1987-01-07 | — | — | EP | claimed |
| US-4562287-A | ANALGESICS | SCHARPER S.P.A. PER L'INDUSTRIA FARMACEUTICA (IT) | 1985-12-31 | — | — | US | claimed |
| US-4533546-A | PHENYLACTIC ACID COMPOUND AND CARBOXYVINYL POLYMER WITH AN AMINE AND AN ALCOHOL | LEDERLE (JAPAN), LTD. (JP) | 1985-08-06 | — | — | US | claimed |
| US-4529737-A | Analgesic and anti-inflammatory arylalkanoic acid phthalidyl esters and pharmaceutical compositions thereof | RESFAR S.R.I. (IT) | 1985-07-16 | — | — | US | claimed |
| EP-0127840-A1 | Antiinflammatory analgesic gelled ointments | LEDERLE (JAPAN) LTD. (JP) | 1984-12-12 | — | — | EP | claimed |
| US-3991206-A | Alleviation of eye inflammation by topical application of p-biphenylacetic acid | AMERICAN CYANAMID COMPANY (US) | 1976-11-09 | — | — | US | claimed |
| US-3966978-A | 4-Biphenylacetic acid as an inhibitor of platelet aggregation | AMERICAN CYANAMID COMPANY (US) | 1976-06-29 | — | — | US | claimed |